financetom
Business
financetom
/
Business
/
OFI Global China Fund to sell 5.2 cr shares of Zee Entertainment to raise Rs 1396 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OFI Global China Fund to sell 5.2 cr shares of Zee Entertainment to raise Rs 1396 cr
Oct 17, 2022 10:34 AM

OFI Global China Fund on Monday, October 17, has decided to sell up to 5.2 crore shares, representing 5.51 percent of Zee Entertainment Enterprises Ltd's (ZEEL) outstanding shares, through a block deal to raise Rs 1,396 crore.

Share Market Live

NSE

The company has offered shares in the price band of Rs 250 to Rs 263.7 and there will be a lock-in period of 180 days on OFI post this stake sale. Kotak Securities Ltd will be acting as the sole broker for the deal.

Currently, investment firm Invesco, along with OFI Global China Fund LLC holds 11 percent stake in ZEEL. Invesco is the largest shareholder in ZEEL.

Recently, the Competition Commission of India (CCI) approved with certain conditions the mega-merger deal between media groups Sony and Zee. In a tweet, the watchdog said it has cleared the deal with certain modifications. The proposed merger was announced in September last year.

Also Read: ICICI Direct says buy these 10 stocks during Diwali 2022

ZEEL, in September 2021, said it has entered into a non-binding term sheet with Sony Pictures Networks India (SPNI) to bring together their linear networks, digital assets, production operations and programme libraries.

The combined entity will own over 70 TV channels, two video streaming services (ZEE5 and Sony LIV) and two film studios (Zee Studios and Sony Pictures Films India), making it the largest entertainment network in India, ZEEL said in September last year.

CME, earlier known as Sony Pictures Networks India Pvt Ltd (SPNI), Bangla Entertainment Pvt Ltd (BEPL), ZEEL and Essel Group, are part of the combination, as per the notice filed with CCI in April 2022.

Also Read: Diwali 2022: These companies rewarded employees with extravagant gifts

(Edited by : Shoma Bhattacharjee)

First Published:Oct 17, 2022 7:34 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved